Inborn errors of metabolism in infancy and early childhood: An update

American Family Physician

Volumn 73, Issue 11, 2006, Pages 1981-1990

  Raghuveer, Talkad S ^a,c   Garg, Uttam ^b,d   Graf, William D ^b,d  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ARGININE; BENZOIC ACID; BETA GLUCOSIDASE; BICARBONATE; CYANOCOBALAMIN; GLUCOSYLCERAMIDASE; PYRIDOXINE; SODIUM CARBONATE; TYROSINE;

DIET RESTRICTION; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DRUG DOSE REGIMEN; EARLY DIAGNOSIS; ENZYME REPLACEMENT; ESSENTIAL FATTY ACID DEFICIENCY; GALACTOSEMIA; GAUCHER DISEASE; HUMAN; HYPERAMMONEMIA; HYPOGLYCEMIA; INBORN ERROR OF METABOLISM; LABORATORY TEST; LONG TERM CARE; METABOLIC ACIDOSIS; METABOLIC DISORDER; METHYLMALONIC ACIDURIA; NEWBORN SCREENING; ORGAN TRANSPLANTATION; PHENYLKETONURIA; PRIMARY MEDICAL CARE; PROTEIN RESTRICTION; REVIEW; SEIZURE; TANDEM MASS SPECTROMETRY; UNITED STATES;

CHILD, PRESCHOOL; DIAGNOSTIC TECHNIQUES AND PROCEDURES; EARLY DIAGNOSIS; HUMANS; INFANT; INFANT, NEWBORN; METABOLISM, INBORN ERRORS; NEONATAL SCREENING;

EID: 33744959980     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Beaudet AL, Scriver CR, Sly WS, Valle D. Molecular bases of variant human phenotypes. In: Scriver CR, ed. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill, 2001:3-51.
2. Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics 2000;105:e10.
3. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999;281:249-54.
4. Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 2003;348:2304-12.
5. Holtzman NA. Expanding newborn screening: how good is the evidence? JAMA 2003;290:2606-8.
6. Waisbren SE, Albers S, Amato S, Ampola M, Brewster TG, Demmer L, et al. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA 2003;290:2564-72.
7. University of Texas Health Science Center at San Antonio. National Newborn Screening and Genetics Resource Center. Accessed online January 10, 2006, at: http://genes-r-us.uthscsa.edu.
8. Clarke JT. A Clinical Guide to Inherited Metabolic Diseases. 2nd ed. New York: Cambridge University Press, 2002.
9. Blau N, Duran M, Blaskovics ME, Gibson KM. Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases. 2nd ed. New York: Springer, 2003.
10. Novotny E, Ashwal S, Shevell M. Proton magnetic resonance spectroscopy: an emerging technology in pediatric neurology research. Pediatr Res 1998;44:1-10.
11. Prasad A, Kaye EM, Alroy J. Electron microscopic examination of skin biopsy as a cost-effective tool in the diagnosis of lysosomal storage diseases. J Child Neurol 1996;11:301-8.
12. Levy HL, Ghavami M. Maternal phenylketonuria: a metabolic teratogen. Teratology 1996;53:176-84.
13. GeneTests. National Institutes of Health. Accessed online January 10, 2006, at: http://www.genetests.org.
14. National Human Genome Research Institute. National Institutes of Health. Accessed online January 10, 2006, at: http://www.genome.gov/.
15. American Society of Human Genetics. Accessed online January 10, 2006, at: http://www.ashg.org.